These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29448106)

  • 1. Folic acid prevents methotrexate-induced epithelial-mesenchymal transition via suppression of secreted factors from the human alveolar epithelial cell line A549.
    Kawami M; Harabayashi R; Harada R; Yamagami Y; Yumoto R; Takano M
    Biochem Biophys Res Commun; 2018 Feb; 497(1):457-463. PubMed ID: 29448106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation on inhibitory effect of folic acid on methotrexate-induced epithelial-mesenchymal transition focusing on dihydrofolate reductase.
    Kawami M; Honda N; Hara T; Yumoto R; Takano M
    Drug Metab Pharmacokinet; 2019 Dec; 34(6):396-399. PubMed ID: 31601464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate-Induced Epithelial-Mesenchymal Transition in the Alveolar Epithelial Cell Line A549.
    Kawami M; Harabayashi R; Miyamoto M; Harada R; Yumoto R; Takano M
    Lung; 2016 Dec; 194(6):923-930. PubMed ID: 27604426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of plasminogen activator inhibitor-1 in methotrexate-induced epithelial-mesenchymal transition in alveolar epithelial A549 cells.
    Yamagami Y; Kawami M; Ojima T; Futatsugi S; Yumoto R; Takano M
    Biochem Biophys Res Commun; 2020 May; 525(3):543-548. PubMed ID: 32113686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of Drug-induced Lung Injury for the Development of a Novel Therapeutic Approach].
    Kawami M
    Yakugaku Zasshi; 2020; 140(1):15-22. PubMed ID: 31902879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of epithelial-mesenchymal transition in methotrexate-induced pulmonary fibrosis.
    Ohbayashi M; Kubota S; Kawase A; Kohyama N; Kobayashi Y; Yamamoto T
    J Toxicol Sci; 2014 Apr; 39(2):319-30. PubMed ID: 24646714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of integrin α2 in methotrexate-induced epithelial-mesenchymal transition in alveolar epithelial A549 cells.
    Kawami M; Ojima T; Yumoto R; Takano M
    Toxicol Res; 2022 Oct; 38(4):449-458. PubMed ID: 36277370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Nrf2 in Methotrexate-Induced Epithelial-Mesenchymal Transition in Alveolar A549 Cells.
    Kawami M; Honda M; Hara T; Yumoto R; Takano M
    Biol Pharm Bull; 2022; 45(8):1069-1076. PubMed ID: 35908888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of TGF-β1- and drug-induced epithelial-mesenchymal transition in cultured alveolar epithelial cell line RLE/Abca3.
    Takano M; Yamamoto C; Yamaguchi K; Kawami M; Yumoto R
    Drug Metab Pharmacokinet; 2015 Feb; 30(1):111-8. PubMed ID: 25760538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of cell cycle arrest with anticancer drug-induced epithelial-mesenchymal transition in alveolar epithelial cells.
    Kawami M; Harada R; Ojima T; Yamagami Y; Yumoto R; Takano M
    Toxicology; 2019 Aug; 424():152231. PubMed ID: 31170432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Drug-Induced Epithelial-Mesenchymal Transition via p53/miR-34a axis in A549/ABCA3 Cells.
    Yamamoto A; Kawami M; Konaka T; Takenaka S; Yumoto R; Takano M
    J Pharm Pharm Sci; 2019; 22(1):516-524. PubMed ID: 31603744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential mechanisms underlying methotrexate-induced cell death and epithelial-mesenchymal transition in A549 cells.
    Ojima T; Kawami M; Yumoto R; Takano M
    Toxicol Res; 2021 Jul; 37(3):293-300. PubMed ID: 34295794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraquat induces epithelial-mesenchymal transition-like cellular response resulting in fibrogenesis and the prevention of apoptosis in human pulmonary epithelial cells.
    Yamada A; Aki T; Unuma K; Funakoshi T; Uemura K
    PLoS One; 2015; 10(3):e0120192. PubMed ID: 25799450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate influx via folate transporters into alveolar epithelial cell line A549.
    Kawami M; Miyamoto M; Yumoto R; Takano M
    Drug Metab Pharmacokinet; 2015 Aug; 30(4):276-81. PubMed ID: 26190800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-catenin induces A549 alveolar epithelial cell mesenchymal transition during pulmonary fibrosis.
    Song P; Zheng JX; Xu J; Liu JZ; Wu LY; Liu C
    Mol Med Rep; 2015 Apr; 11(4):2703-10. PubMed ID: 25435076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propolis inhibits TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells via PPARγ activation.
    Kao HF; Chang-Chien PW; Chang WT; Yeh TM; Wang JY
    Int Immunopharmacol; 2013 Mar; 15(3):565-74. PubMed ID: 23328619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation.
    Tomei P; Masola V; Granata S; Bellin G; Carratù P; Ficial M; Ventura VA; Onisto M; Resta O; Gambaro G; Chilosi M; Lupo A; Zaza G
    J Nephrol; 2016 Dec; 29(6):881-891. PubMed ID: 27026415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinase-activated receptor 4 stimulation-induced epithelial-mesenchymal transition in alveolar epithelial cells.
    Ando S; Otani H; Yagi Y; Kawai K; Araki H; Fukuhara S; Inagaki C
    Respir Res; 2007 Apr; 8(1):31. PubMed ID: 17433115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-4F, an apolipoprotein A-I mimetic, inhibits TGF-β1 induced epithelial-mesenchymal transition in human alveolar epithelial cell.
    You J; Wang J; Xie L; Zhu C; Xiong J
    Exp Toxicol Pathol; 2016 Oct; 68(9):533-541. PubMed ID: 27495007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL9 Regulates TGF-β1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells.
    O'Beirne SL; Walsh SM; Fabre A; Reviriego C; Worrell JC; Counihan IP; Lumsden RV; Cramton-Barnes J; Belperio JA; Donnelly SC; Boylan D; Marchal-Sommé J; Kane R; Keane MP
    J Immunol; 2015 Sep; 195(6):2788-96. PubMed ID: 26268659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.